STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock

Daniela Herzig1, Geping Fang, Tracy E Toliver-Kinsky

  • 1Department of Anesthesiology, The University of Texas Medical Branch and Shriners Hospital for Children, Galveston, Texas, USA.

Shock (Augusta, Ga.)
|July 11, 2012
PubMed

Insights

Mice lacking STAT1 (signal transducer and activator of transcription 1) showed improved survival and reduced organ injury during septic shock. TYK2 deficiency also attenuated inflammation but did not improve survival, indicating STAT1

Area of Science:

  • Immunology and Molecular Biology
  • Sepsis Pathogenesis

Background:

  • Signal transducer and activator of transcription 1 (STAT1) is crucial for interferon receptor signaling and gene transcription.
  • STAT1-deficient mice exhibit resistance to endotoxin-induced shock.
  • Tyrosine kinase 2 (TYK2) is essential for type I interferon-induced STAT1 activation.

Purpose of the Study:

  • To investigate the roles of STAT1 and TYK2 in the response to cecal ligation and puncture (CLP)-induced septic shock.
  • To evaluate survival rates, organ injury, cytokine production, and bacterial clearance in STAT1- and TYK2-deficient mice.

Main Methods:

  • Utilized STAT1 knockout (STAT1KO) and TYK2-deficient mouse models.
  • Induced septic shock using the cecal ligation and puncture (CLP) model.
  • Monitored survival, core body temperature, metabolic parameters, organ injury markers, plasma cytokine levels, and bacterial counts.

Main Results:

  • STAT1KO mice demonstrated significantly higher survival rates (80% vs. 10%) compared to wild-type controls following CLP.
  • Improved survival in STAT1KO mice was linked to reduced hypothermia, metabolic acidosis, hypoglycemia, and hepatocellular injury.
  • STAT1KO mice exhibited lower plasma levels of IL-6, MIP-2, CXCL10, and IFN-α, and reduced bacterial load.

Conclusions:

  • STAT1 activation is a critical factor in the pathogenesis of CLP-induced septic shock, contributing to systemic inflammation and organ damage.
  • TYK2 plays a role in CLP-induced inflammation, but its absence does not confer a survival advantage.
  • Targeting STAT1 may offer a therapeutic strategy for mitigating sepsis severity.

Related Concept Videos